Medicare Enrolled
Dr. Mohamed Ghumra, MD
Neurology · Elgin, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ghumra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ghumra?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ghumra
Dr. Mohamed Ghumra is a neurology specialist in Elgin, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ghumra performed 10,735 Medicare services across 1,288 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ghumra received a total of $18,113 from 84 pharmaceutical and/or device companies across 1106 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ghumra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in IL
$18,113 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,735
Medicare services
Top 6% in IL for neurology
1,288
Unique beneficiaries
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~537 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
9,000 | $5 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
880 | $94 | $229 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
201 | $121 | $359 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
175 | $80 | $460 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
84 | $8 | $20 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
63 | $168 | $1,250 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
45 | $124 | $925 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
35 | $5 | $26 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
34 | $4 | $20 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
33 | $15 | $77 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
27 | $14 | $77 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
26 | $103 | $750 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
23 | $320 | $834 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $58 | $157 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
21 | $3 | $14 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
15 | $5 | $27 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
14 | $371 | $957 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $85 | $235 |
| Autoimmune disorder screening test A laboratory test used to screen for the presence of autoimmune disorders. |
12 | $12 | $62 |
| Rheumatoid factor level | 12 | $6 | $29 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,113
Total received (2018-2024)
Avg $2,588/year across 7 years
Top 15% in IL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
1,106
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,516 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$597 (3.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,462
2023
$3,581
2022
$2,997
2021
$3,053
2020
$1,455
2019
$2,228
2018
$2,336
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$672
Novartis Pharmaceuticals Corporation
$227
Neurocrine Biosciences, Inc.
$166
Celgene Corporation
$165
BANNER LIFE SCIENCES, LLC
$153
Lilly USA, LLC
$144
PFIZER INC.
$141
UCB, Inc.
$115
MDD US Operations, LLC
$99
CATALYST PHARMACEUTICALS, INC.
$68
Otsuka America Pharmaceutical, Inc.
$54
Eisai Inc.
$54
Genentech USA, Inc.
$49
Sumitomo Pharma America, Inc.
$44
Amgen Inc.
$43
Lundbeck LLC
$38
SK Life Science, Inc.
$36
Biogen, Inc.
$25
Azurity Pharmaceuticals, Inc.
$22
Neurelis, Inc.
$21
JAZZ PHARMACEUTICALS INC.
$19
Ipsen Biopharmaceuticals, Inc
$19
Takeda Pharmaceuticals U.S.A., Inc.
$19
Averitas Pharma Inc.
$18
Acorda Therapeutics, Inc
$18
ARGENX US, INC.
$18
ACADIA Pharmaceuticals Inc
$15
Top 3 companies account for 43.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,617
ABBVIE INC.
$1,552
Teva Pharmaceuticals USA, Inc.
$887
Biogen, Inc.
$743
Amgen Inc.
$691
Lundbeck LLC
$585
LivaNova USA, Inc.
$568
Harmony Biosciences LLC
$558
Lilly USA, LLC
$539
Celgene Corporation
$538
GENZYME CORPORATION
$532
EMD Serono, Inc.
$521
BANNER LIFE SCIENCES, LLC
$503
Alexion Pharmaceuticals, Inc.
$466
Genentech USA, Inc.
$458
Neurocrine Biosciences, Inc.
$454
UCB, Inc.
$452
PFIZER INC.
$421
SK Life Science, Inc.
$377
Horizon Therapeutics plc
$319
AbbVie Inc.
$266
Adamas Pharmaceuticals, Inc.
$262
Biohaven Pharmaceuticals, Inc.
$251
Eisai Inc.
$236
Biohaven Pharmaceutical Holding Company Ltd.
$223
Sunovion Pharmaceuticals Inc.
$217
Janssen Pharmaceuticals, Inc
$216
Acorda Therapeutics, Inc
$216
Allergan, Inc.
$212
MDD US Operations, LLC
$189
JAZZ PHARMACEUTICALS INC.
$166
CATALYST PHARMACEUTICALS, INC.
$162
ACADIA Pharmaceuticals Inc
$157
Avion Pharmaceuticals
$129
Promius Pharma LLC
$126
Sumitomo Pharma America, Inc.
$122
Corium, LLC
$116
HARMONY BIOSCIENCES LLC
$111
Upsher-Smith Laboratories LLC
$104
Takeda Pharmaceuticals U.S.A., Inc.
$95
Catalyst Pharmaceuticals, Inc.
$92
Otsuka America Pharmaceutical, Inc.
$87
Vertical Pharmaceuticals, LLC
$85
Supernus Pharmaceuticals, Inc.
$85
Grifols USA, LLC
$83
Bausch Health US, LLC
$77
Avanir Pharmaceuticals, Inc.
$73
Azurity Pharmaceuticals, Inc.
$65
Amneal Pharmaceuticals LLC
$63
Axsome Therapeutics, Inc.
$56
Neurelis, Inc.
$53
ARBOR PHARMACEUTICALS, INC.
$51
Vanda Pharmaceuticals Inc.
$49
IMPEL PHARMACEUTICALS INC.
$49
Ipsen Biopharmaceuticals, Inc
$48
Mallinckrodt LLC
$46
ARGENX US, INC.
$45
E.R. Squibb & Sons, L.L.C.
$42
Allergan Inc.
$40
Mallinckrodt Hospital Products Inc.
$40
Banner Life Sciences, LLC
$38
EISAI INC.
$35
Merck Sharp & Dohme LLC
$34
US WorldMeds, LLC
$33
Abbott Laboratories
$32
AbbVie, Inc.
$31
IDORSIA PHARMACEUTICALS US INC
$28
Collegium Pharmaceutical, Inc.
$27
Mallinckrodt Enterprises LLC
$24
Medtronic, Inc.
$21
Boston Scientific Corporation
$19
UPSHER-SMITH LABORATORIES LLC
$18
CSL Behring
$18
Averitas Pharma Inc.
$18
SANOFI-AVENTIS U.S. LLC
$17
Xeris Pharmaceuticals, Inc.
$16
Impax Laboratories, Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$16
Metacel Pharmaceuticals LLC
$15
Shire North American Group Inc
$15
Jazz Pharmaceuticals Inc.
$15
OWP Pharmaceuticals, Inc.
$15
Assertio Therapeutics, Inc.
$14
Alnylam Pharmaceuticals Inc.
$11
Top 3 companies account for 22.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · ADUHELM · AGAMREE · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · Briviact · COPAXONE · Cambia · DUEXIS · DYSPORT · Dhivy · Duopa · Dysport · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Enspryng · FANAPT · FIRDAPSE · FYCOMPA · Fycompa · GAMMAGARD · GOCOVRI · Gamunex-C · Gocovri · HETLIOZ · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LYRICA · Leqembi · MAYZENT · MIGRANAL · Mavenclad · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Natazia · OCREVUS · ONFI · ONGENTYS · ONPATTRO · ONZETRA Xsail · OSMOLEX ER · Ocrevus · Ongentys · Ozobax · PANZYGA · POMPE - DISEASE · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · QUVIVIQ · RAYOS · RELEXXII · REXULTI · RYTARY · Rebif · Repatha · Rystiggo · SOLIRIS · SUNOSI · Soliris · Subvenite · Sunosi · TOSYMRA · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · Vimpat · WAKIX · Wakix · XCOPRI · XYWAV · Xadago · Xembify · Xyrem · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · Zembrace · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
158
Per 100K population
30.6
County median income
$100,678
Nearest hospital
ADVOCATE SHERMAN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ghumra is a mixed practice specialist, with above-average Medicare volume (top 6% in IL), with low-engagement industry engagement in the top 15% of IL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ghumra experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Ghumra performed 9,000 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ghumra receive payments from pharmaceutical companies?
Yes. Dr. Ghumra received a total of $18,113 from 84 companies across 1,106 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ghumra's costs compare to other neurologists in Elgin?
Dr. Ghumra's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ghumra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Elgin
Browse neurologists in Elgin ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in IL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in IL
Which IL neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology